Related Experiment Video
Updated: Jun 9, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells
Dong Gui Hu1, Peter I Mackenzie
1Department of Clinical Pharmacology, Flinders University School of Medicine, Flinders Medical Centre, Bedford Park SA 5042, Australia.
Abstract:
The UDP-glucuronosyltransferases (UGTs) 2B15 and 2B17 are the major UGTs involved in the inactivation and elimination of the active androgens, dihydrotestosterone and testosterone. Although regulation of these UGT genes by various endogenous and exogenous ligands, including steroid hormones and bile acids, is well documented, the mechanisms controlling their basal gene expression are poorly understood. We recently reported that Forkhead box protein A1 (FOXA1) regulates the basal expression of the UGT2B17 gene in prostate cancer cells. In this study, we show that FOXA1 also regulates basal expression of the UGT2B15 gene in the prostate cell line LNCaP (lymph node carcinoma of the prostate). FOXA1 binds to a site -208 to -217 base pairs relative to the UGT2B15 translation start site, as shown by electromobility shift and chromatin immunoprecipitation assays. Mutation of this site prevents binding and substantially decreases basal UGT2B15 promoter activity. Silencing of FOXA1 expression by small interfering RNA significantly reduced UGT2B15 transcript levels, further confirming a crucial role of FOXA1 in controlling UGT2B15 gene expression. Because local inactivation of active androgens by UGT2B15 and UGT2B17 has been shown to be a major determinant of androgen response and signaling activity, regulation of the UGT2B15 and UGT2B17 genes by FOXA1 may have an important role in the maintenance of androgen homeostasis within prostate cancer cells.
Insights
Forkhead box protein A1 (FOXA1) regulates the basal expression of UGT2B15, a key enzyme in androgen inactivation. This finding is crucial for understanding androgen homeostasis in prostate cancer cells.
Area of Science:
- Molecular Biology
- Endocrinology
- Cancer Biology
Background:
- UDP-glucuronosyltransferases (UGTs) 2B15 and 2B17 are critical for inactivating androgens like testosterone.
- Basal gene expression mechanisms for UGT2B15 and UGT2B17 are not well understood.
- Previous research identified Forkhead box protein A1 (FOXA1) as a regulator of UGT2B17 in prostate cancer.
Purpose of the Study:
- To investigate the role of FOXA1 in regulating the basal expression of the UGT2B15 gene.
- To elucidate the molecular mechanisms by which FOXA1 controls UGT2B15 expression in prostate cancer cells.
Main Methods:
- Electromobility shift assays (EMSA) and chromatin immunoprecipitation (ChIP) to identify FOXA1 binding sites on the UGT2B15 gene.
- Site-directed mutagenesis to assess the impact of FOXA1 binding on UGT2B15 promoter activity.
- Small interfering RNA (siRNA) to silence FOXA1 expression and measure UGT2B15 transcript levels.
Main Results:
- FOXA1 binds to a specific site (-208 to -217 bp) upstream of the UGT2B15 translation start site.
- Mutation of this binding site significantly reduced UGT2B15 promoter activity.
- Silencing FOXA1 expression led to a significant decrease in UGT2B15 transcript levels.
Conclusions:
- FOXA1 plays a crucial role in regulating the basal expression of the UGT2B15 gene in prostate cancer cells.
- FOXA1-mediated regulation of UGT2B15 and UGT2B17 may be important for maintaining androgen homeostasis in prostate cancer.
Related Concept Videos
Cell Specific Gene Expression
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Canonical Wnt Signaling Pathway
Regulation of Nuclear Protein Sorting
Regulation of Expression at Multiple Steps
Co-activators and Co-repressors

